Mastering complexity to
accelerate discovery.

We bridge the gap between complex neuroimaging data and actionable research insights. Our focus is empowering pre-clinical researchers to streamline workflows and enhance the quality of life-science outcomes.

Our Mission

Neuroscience Simplified.

At NeuroSimplicity, we recognize that the greatest constraint in modern neuroscience is no longer data acquisition—it is actionable integration. As cutting-edge modalities generate increasingly complex and massive datasets, the methods for standardized, reproducible analysis have lagged critically behind.

Our mission is to enable scientists and clinicians to focus entirely on discovery and care, by replacing technical bottlenecks with powerful, seamless solutions. This mission is realized through The Imaging Suite, NeuroSimplicity's foundational technology platform. The Imaging Suite reliably integrates neuroscientific data across all scales—from anatomical imaging to molecular and functional -omics data. This approach is setting the new standard for how preclinical and clinical research will unify disparate data streams, accelerating medical breakthroughs.


Technical Validation

Foundational Rigor: Proprietary Platform, Peer-Reviewed Results

Our solutions are built on a bedrock of scientific excellence. We develop novel, proprietary algorithms that not only streamline complex neuroimaging analysis but have been rigorously tested and validated by our team's fundamental work published in the world's leading scientific journals.

VALIDATEDScientific Foundation

Validation of our platform and methodologies published in journals including Nature, Cell Reports Methods, and STAR Protocols.

SECUREDGlobal Patent Portfolio

Protecting our novel cross-scale data integration algorithms with extensive US and international patent coverage.

ESTABLISHEDInstitutional Clients

Initial installations at leading academic and commercial research centers, rapidly forming our exclusive early adopter network and driving future platform enhancements.


Technical Leadership

Our Technical Leadership Team

Jared S. Rosenblum, MD Headshot

Jared S. Rosenblum, MD

Founder & President

Jared is the founder of NeuroSimplicity. His unique background ensures our advanced software solutions directly address critical laboratory workflow challenges.

His expertise was forged during fellowships in translational science at the Neurosurgery Department at Brigham and Women's Hospital, Harvard University, and the Neuro-Oncology and Surgical Neurology Branches of the National Institutes of Health (NIH).

  • This grounding enables him to fluently translate complex neuroimaging data into actionable insights.
  • Technology development work assures clients that our platforms deliver peer-reviewed scientific rigor, reproducibility, and demonstrable time savings.
Bruce R. Rosenblum, MD, F.A.C.S. Headshot

Bruce R. Rosenblum, MD, F.A.C.S.

Chief Medical Officer

Bruce brings over 35 years of neurosurgical experience and a proven history as an early adopter of cutting-edge clinical technology to NeuroSimplicity.

His experience ensures our software is grounded in practical clinical and institutional needs. He successfully championed the adoption of complex technologies like the Brainlab intraoperative suite and advanced radiation platforms such as Cyberknife.

  • This background gives him deep, practical understanding of workflow optimization and clinical integration.
  • Completed fellowship in the Surgical Neurology Branch of the National Institutes of Health (NIH), where he developed new imaging techniques.

Distributors

Global Distribution & Local Partnerships

Expanding Coverage Globally

Focused on You. Wherever You Are.

NeuroSimplicity partners with established leaders in the scientific supply chain to ensure seamless delivery and support of our automated neuroimaging solutions.

Featured U.S. Partner(NJ Territory)

Avantor Sciences / VWR

Providing sales and support for institutions across New Jersey.

Connect with us.

Follow our journey and stay updated on the latest developments.